Visit https://www.peervoice.com/TXH860 to view the entire programme with slides. After completing “Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer”, participants will be able to: Recall safety and efficacy data of HER3-targeted therapies in the management of non-small cell lung cancer (NSCLC) and breast cancer; and Recognise ongoing questions on targeting HER3 and how to solve them.